4//SEC Filing
Grant Stuart 4
Accession 0001127602-10-020812
CIK 0000882796other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 12:42 PM ET
Size
8.3 KB
Accession
0001127602-10-020812
Insider Transaction Report
Form 4
Grant Stuart
SR VP & CFO
Transactions
- Exercise/Conversion
Emp. Stock Option (Right to Buy)
2010-08-04−2,500→ 103,751 totalExercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2010-08-04$1.20/sh+2,500$3,000→ 14,217 total - Sale
Common Stock
2010-08-04$6.20/sh−2,500$15,500→ 11,717 total
Footnotes (1)
- [F1]Transacted under a 10b5-1 plan that was adopted on 11/23/2009.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001410397
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 12:42 PM ET
- Size
- 8.3 KB